Rhea-AI Summary
Accendra Health (ACH) received notice that NYSE trading was suspended effective November 16, 2026, and delisting proceedings would begin. The NYSE cited abnormally low selling price levels under Rule 802.01D. The common stock began trading on the OTCQB market as ACCH on November 17, 2026.
The company said the transition will not affect business operations or SEC reporting obligations and does not conflict with, or trigger a default under, any material debt or other agreements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags